A Phase I Study of DE-766 with Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Cancer
Latest Information Update: 29 Mar 2018
At a glance
- Drugs Nimotuzumab (Primary) ; Cisplatin; Fluorouracil
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions
- Sponsors Daiichi Sankyo Company
- 01 Mar 2018 Results of study assessing safety, tolerability, efficacy and pharmacokinetics published in the Cancer Science
- 07 Jun 2016 New trial record